Reference 2017-486

REF:            2017-486

Subject:        Biologics in Dermatology and activity in Atopic Dermatitis




  1. Is it your Trust/CCG policy to wait until 90 days post NICE guidance to fund new drugs or do they fund earlier?
  2. What is your Trust/CCG policy re use of Zero Risk (ZR)/Early Use Schemes (EUS), i.e. where a medicine is made available free of charge or at a reduced price to the NHS whilst awaiting NICE/SMC approval, in lieu of NICE?
  3. What is the process for getting such ZR/EUS schemes implemented/approved/signed off within your Trust/hospital? Who needs to sign the contracts for such schemes?


IFR/Cohort Funding;

FOA: Dermatology Lead Pharmacist / Dermatology Department Clinical Director

  1. What is your Trust’s policy re Individual Funding Request and/or Cohort Funding policy? Ref: IFR/Cohort Funding

  1. Do you have a pathway/preferential prescribing list, illustrating sequential use of Biologics in Dermatology? What does this recommend?
  2. How many lines/trials of biologics are allowed/funded for the management of psoriasis within your trust/CCG? What happens if a clinician needs to exceed this?
  3. If there is a biologics psoriasis pathway – how often is it updated to reflect changes to NICE status of new therapies?
  4. If there is no formulary/pathway – what do the Trust/CCG utilise in order to guide use of biologics in the management of psoriasis?


Atopic Dermatitis

FAO: Dermatology Service Manager

  1. How many patients attended for a new outpatient appointment in dermatology Utilising ICD-10 classification -L20Atopic Dermatitis (Eczema) – from April 2015 – March 2016?

10.The number of paediatric attendances of patients utilising ICD-10 classification – L20 for Atopic Dermatitis (Eczema) – from April 2015 – March 2016?

  1. Does your Trust have a paediatric dermatologist? Does your Trust have a paediatrician with a dermatology interest/specialism?




Please find information attached.

2017-486 – FOI request – Biologics in Dermatology and activity in Atopic Dermatitis [222 kb] PDF